We are monitoring the impact of COVID-19 on Europe Lyme Disease Diagnostic Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5312
Share on
Share on

Europe Lyme Disease Diagnostic Market Research Report - Segmented By Dark field microscopy, Diagnostic Technologies, End User & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 5312
Pages: 145

Europe Lyme Disease Diagnostic Market Size & Growth (2019 – 2024):

According to the Report, the Size of the Lyme Disease Diagnostics Market in Europe is valued at USD xx Million in 2019 and is anticipated to reach a CAGR of xx%, to reach USD xx Million by 2024, during the forecast period 2019-2024.

Lyme disease is an infectious disease which is caused by bacteria borrelia. It is a tick borne disease caused by the bite of infected ticks. Fever, depression, fatigue and skin rashes are some of the symptoms of lyme disease. It can be treated with antibiotics if it is diagnosed in early stages. But, if the disease is untreated then it affects heart, joint and central nervous system and may cause death

Increasing incidences of Lyme diseaseis expected to be the major growth factor during the forecast period. However inefficiency in lyme disease testing is a major restraint.

Europe Lyme Disease Diagnostic Market has been segmented and sub-segmented into the following categories

  • By Darkfield microscopy: Urine antigen tests, lymphocytic transformation test, Serological tests, immunofluorescence staining, PCR tests.
  • By Diagnostic Technologies: Molecular diagnostics, Monoclonal antibodies, Flow cytometry, Brain MRI, Spinal tap, Echocardiogram, Electrocardiogram, Microdroplets.
  • By End User: hospitals/clinics, Pharmaceutical Industries, Pathology labs, Research Institutes.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

On the basis of region, Europe is assumed as a developed market and is anticipated to witness significant growth in the forecast period.

Prominent Companies leading the Europe Lyme Disease Diagnostics Market Profiled in the Report are Boulder Diagnostics, Immunetics Inc, GlaxoSmithKline Pharmaceuticals Ltd, Bio-Rad Laboratories, Alere Inc (ALR), Roche Diagnostics International Ltd, Graphene Frontiers, Covance Inc, Affymetrix Inc, Siemens AG, Baxter International Inc, Fresenius Medical Care AG & Co.,

1. Introduction       

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Diagnostic Tests                        

      5.1.1 Introduction           

      5.1.2 Serological tests    

                      5.1.2.1 ELISA (Enzyme-linked Immunosorbent Assay)

                      5.1.2.2 ELFA (Enzyme-linked Fluorescent Immunoassay)

                      5.1.2.3 Western Blot

      5.1.3 Lymphocytic transformation test  

      5.1.4 Immunofluorescence staining        

      5.1.5 PCR Analysis           

      5.1.6 Urine antigen tests              

      5.1.7 Darkfield microscopy         

      5.1.8  Y-o-Y Growth Analysis, By Diagnostic Tests              

      5.1.9  Market Attractiveness Analysis, By Diagnostic Tests            

      5.1.10  Market Share Analysis, By Diagnostic Tests           

                5.2 Diagnostic Technologies                        

      5.2.1 Introduction           

      5.2.2 Molecular diagnostics         

      5.2.3 Brain MRI 

      5.2.4 Spinal tap 

      5.2.5 Echocardiogram    

      5.2.6 Electrocardiogram

      5.2.7 Monoclonal antibodies      

      5.2.8 Flow cytometry     

      5.2.9 Gel micro droplets               

      5.2.10 Y-o-Y Growth Analysis, By Diagnostic Technologies             

      5.2.11 Market Attractiveness Analysis, By Diagnostic Technologies           

      5.2.12 Market Share Analysis, By Diagnostic Technologies            

                5.3 End Users                    

      5.3.1 Introduction           

      5.3.2 Hospitals / Clinics  

      5.3.3 Pharmaceutical Industries

      5.3.4 Pathology labs       

      5.3.5 Research Institutes             

      5.3.6 Y-o-Y Growth Analysis, By End Users           

      5.3.7  Market Attractiveness Analysis, By End Users        

      5.3.8  Market Share Analysis, By End Users          

6. Geographical Analysis                    

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Diagnostic Tests

                      6.1.3.3 By Diagnostic Technologies

                      6.1.3.4 By End Users

      6.1.4  Market Attractiveness Analysis     

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Diagnostic Tests

                      6.1.4.3 By Diagnostic Technologies

                      6.1.4.4 By End Users

      6.1.5  Market Share Analysis      

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Diagnostic Tests

                      6.1.5.3 By Diagnostic Technologies

                      6.1.5.4 By End Users

                6.2 U.K                 

                6.3 Spain   

                6.4 Germany                     

                6.5 Italy     

                6.6 France

                 6.7 Rest of Europe

7. Strategic Analysis             

                7.1 PESTLE analysis                         

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis              

                8.1 Abbott Laboratories     

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 Siemens AG     

                8.3 GlaxoSmithKline Pharmaceuticals Ltd.  

                8.4 Fresenius Medical Care AG & Co.                      

                8.5 Baxter International Inc.                       

                8.6 Affymetrix Inc.

                8.7 Immunetics Inc.                        

                8.8 Boulder Diagnostics                

                8.9 Roche Diagnostics International Ltd.                

                8.10 Canon U.S. Life Sciences                     

9. Competitive Landscape                 

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                 

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2019-2024 ( USD Million )
  2. Europe Serological tests Market By Region, From 2019-2024 ( USD Million )
  3. Europe Lymphocytic transformation test Market By Region, From 2019-2024 ( USD Million )
  4. Europe Immunofluorescence staining Market By Region, From 2019-2024 ( USD Million )
  5. Europe PCR Analysis  Market By Region, From 2019-2024 ( USD Million )
  6. Europe Urine antigen tests Market By Region, From 2019-2024 ( USD Million )
  7. Europe Dark field microscopy Market By Region, From 2019-2024 ( USD Million )
  8. Europe Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2019-2024 ( USD Million )
  9. Europe Molecular diagnostics Market By Region, From 2019-2024 ( USD Million )
  10. Europe Brain MRI Market By Region, From 2019-2024 ( USD Million )
  11. Europe Spinal tap Market By Region, From 2019-2024 ( USD Million )
  12. Europe Echocardiogram Market By Region, From 2019-2024 ( USD Million )
  13. Europe Electrocardiogram Market By Region, From 2019-2024 ( USD Million )
  14. Europe Monoclonal antibodies Market By Region, From 2019-2024 ( USD Million )
  15. Europe Flow cytometry Market By Region, From 2019-2024 ( USD Million )
  16. Europe Gel micro droplets Market By Region, From 2019-2024 ( USD Million )
  17. Europe Lyme Disease Diagnostic  Market By End Users, From 2019-2024 ( USD Million )
  18. Europe Hospitals / Clinics Market By Region, From 2019-2024 ( USD Million )
  19. Europe Pharmaceutical Industries Market By Region, From 2019-2024 ( USD Million )
  20. Europe Pathology labs Market By Region, From 2019-2024 ( USD Million )
  21. Europe Research Institutes Market By Region, From 2019-2024 ( USD Million )
  22. U.K. Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2019-2024 ( USD Million )
  23. U.K. Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2019-2024 ( USD Million )
  24. U.K. Lyme Disease Diagnostic  Market By End Users, From 2019-2024 ( USD Million )
  25. Germany Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2019-2024 ( USD Million )
  26. Germany Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2019-2024 ( USD Million )
  27. Germany Lyme Disease Diagnostic  Market By End Users, From 2019-2024 ( USD Million )
  28. France Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2019-2024 ( USD Million )
  29. France Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2019-2024 ( USD Million )
  30. France Lyme Disease Diagnostic  Market By End Users, From 2019-2024 ( USD Million )
  31. Italy Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2019-2024 ( USD Million )
  32. Italy Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2019-2024 ( USD Million )
  33. Italy Lyme Disease Diagnostic  Market By End Users, From 2019-2024 ( USD Million )
  34. Spain Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2019-2024 ( USD Million )
  35. Spain Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2019-2024 ( USD Million )
  36. Spain Lyme Disease Diagnostic  Market By End Users, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample